Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
BPC-157 represents one of many compounds attracting attention in this space, though its regulatory status and limited human evidence require acknowledgment
Traditional BPC-157 administration uses subcutaneous injection
They are not intended to represent clinical evidence in humans, and Dihexa has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Each BPC-157 research compound batch is independently verified to 99% HPLC purity, as listed in the Compound Specifications on this page
Graphical Abstract Similar content being viewed by others Introduction Acute pancreatitis is a common abdominal inflammatory condition
The dose response with sleep disruption is roughly linear
US$ 26.89
US$ 28.66
US$ 26.76
US$ 24.07
US$ 21.55
US$ 25.78
US$ 25.07
